SXTCNasdaq

China SXT Pharmaceuticals, Inc.

Pharmaceutical Preparations · D8 · CIK 1723980

China SXT Pharmaceuticals, Inc. is a BVI business company whose affairs are governed by its Memorandum and Articles of Association

+ Watch View on EDGAR ↗

$94M

Market cap

$2.55

Last close

+0.8%

+4.1%

22K

Volume

Price$2.55-99.0%· 1Y

Volume

Jul 10L $1.30 · H $300.00Jul 10

Revenue & earnings

RevenueNet incomeLoss

Fundamentals & quality

Trailing fundamentals · via Polygon & SEC

Rev growth YoY

-34.6%

Trailing 12 months

Gross margin

21.9%

Gross profit / revenue

Net margin

-545.2%

Net income / revenue

ROE

-20.9%

Return on equity

ROIC

-18.5%

Return on invested capital

FCF yield

—

Free cash flow / mkt cap

P/E

—

Price / earnings

P/S

82.3

Price / sales

Similar companies

Comparable business profile · signals at a glance

ZLABZai Lab Ltd$2.2B+2.5%RGCRegencell Bioscience Holdings Ltd$3.1B-3.1%HCMHUTCHMED (China) Ltd$2.0B+0.8%XOMAXOMA Royalty Corp$760.2M-1.3%TCToken Cat Ltd

Filings archive

Newest first · each with a one-line AI read · showing 10 of 74

Jul 6, 20266-KREPORT OF FOREIGN PRIVATE ISSUERChina SXT Pharmaceuticals Inc. entered into a securities purchase agreement to issue and sell up to $30,000,000 of its Class A ordinary shares to an institutional investor. The initial sale of $3,150,000 is expected to close on July 6, 2026, with proceeds for working capital and corporate purposes.Jul 1, 202620-FANNUAL REPORTChina SXT Pharmaceuticals, Inc. reported a net loss of $6,205,085 for the fiscal year ended March 31, 2026, an 88% increase in net loss compared to the prior year. This was primarily driven by a significant increase in general and administrative expenses, which included a $5,305,739 employee incentive.Jun 1, 20266-KREPORT OF FOREIGN PRIVATE ISSUERChina SXT Pharmaceuticals, Inc. entered into a sales agreement to issue and sell up to $100,000,000 of its Class A ordinary shares through an at-the-market offering. The agreement with Univest Securities, LLC, acting as sales agent, outlines the terms for selling shares on the Nasdaq Capital Market or other trading venues.